Wanbury
₹136.3
-3.8 (-2.71%)
10 May, 2024 00:22 BSE: 524212
NSE: WANBURYISIN: INE107F01022
Start SIP in Wanbury
Start SIPWanbury Performance
Day Range
- Low 135
- High 144
52 Week Range
- Low 43
- High 179
- Open Price142
- Previous Close140
- Volume59100
Wanbury Financials
| Indicator | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 |
|---|---|---|---|---|
| Oper Rev Qtr Cr | 145 | 144 | 146 | 133 |
| Operating Expenses Qtr Cr | 124 | 127 | 133 | 119 |
| Operating Profit Qtr Cr | 21 | 17 | 13 | 14 |
| Depreciation Qtr Cr | 3 | 3 | 3 | 3 |
| Interest Qtr Cr | 8 | 8 | 6 | 8 |
| Tax Qtr Cr | 0 | 0 | 0 | 0 |
| Net Profit Qtr Cr | 10 | 7 | 5 | 1 |
Wanbury Technicals
EMA & SMA
Current Price
₹136.3
-3.8 (-2.71%)
- Bullish Moving Average
- ___
- 3
- Bearish Moving Average
- ___
- 13
- 20 Day
- ₹148.65
- 50 Day
- ₹148.87
- 100 Day
- ₹139.74
- 200 Day
- ₹118.99
- 20 Day
- ₹151.28
- 50 Day
- ₹150.77
- 100 Day
- ₹146.47
- 200 Day
- ₹110.05
Wanbury Resistance and Support
PIVOT
₹138.57
| Resistance | |
|---|---|
| First Resistance | 141.83 |
| Second Resistance | 147.37 |
| Third Resistance | 150.63 |
| RSI | 35.91 |
| MFI | 47.54 |
| MACD Single Line | -0.64 |
| MACD | -2.95 |
| Support | |
|---|---|
| First Resistance | 133.03 |
| Second Resistance | 129.77 |
| Third Resistance | 124.23 |
Wanbury Delivery and Volume
| Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
|---|---|---|---|
| Day | 71,456 | 4,954,044 | 69.33 |
| Week | 92,137 | 7,014,405 | 76.13 |
| 1 Month | 119,750 | 9,169,253 | 76.57 |
| 6 Month | 112,759 | 10,743,718 | 95.28 |
Wanbury Result Highlights
Wanbury Synopsis
NSE-Medical-Generic Drugs
Wanbury is involved in the business activities of Manufacture of medicinal substances used in the manufacture of pharmaceuticals: antibiotics, endocrine products, basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, its salts and esters; glycosides and vegetable alkaloids; chemically pure suger etc.. Company’s Total Operating Revenue is Rs. 499.65 Cr. and Equity Capital is Rs. 32.71 Cr. for the Year ended 31/03/2023. Wanbury Ltd. is a Public Limited Listed company incorporated on 11/08/1988 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L51900MH1988PLC048455 and registration number is 048455.| Market Cap | 446 |
| Sales | 569 |
| Shares in Float | 1.96 |
| No of funds | 5 |
| Yield |
| Book Value | 82.61 |
| U/D Vol ratio | 1 |
| LTDebt / Equity | |
| Alpha | 0.42 |
| Beta | 0.83 |
Wanbury
| Owner Name | Mar-24 | Dec-23 | Sep-23 | Jun-23 |
|---|---|---|---|---|
| Promoters | 39.79% | 39.79% | 39.8% | 39.84% |
| Mutual Funds | ||||
| Foreign Portfolio Investors | 0.18% | |||
| Financial Institutions/ Banks | ||||
| Individual Investors | 41.81% | 39.09% | 39.53% | 38.42% |
| Others | 18.22% | 21.12% | 20.67% | 21.74% |
Wanbury Management
| Name | Designation |
|---|---|
| Mr. K Chandran | Vice Chairman & Whole Time Dir |
| Mr. N K Puri | Ind. Non-Executive Director |
| Ms. Pallavi P Shedge | Ind. Non-Executive Director |
Wanbury Forecast
Price Estimates
2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)
Wanbury Corporate Action
| Date | Purpose | Remarks |
|---|---|---|
| 2024-05-16 | Audited Results | |
| 2024-01-24 | Quarterly Results | |
| 2023-10-20 | Quarterly Results & Preferential issue | Inter-alia, to consider and evaluate proposals for raising of funds by way of a preferential issue/allotment and private placement to promoters/promoter group of the Company. |
| 2023-08-11 | Quarterly Results | |
| 2023-06-09 | Audited Results | (Revised) |
Wanbury FAQs
What is Share Price of Wanbury ?
Wanbury share price is ₹136 As on 10 May, 2024 | 00:08
What is the Market Cap of Wanbury ?
The Market Cap of Wanbury is ₹446.3 Cr As on 10 May, 2024 | 00:08
What is the P/E ratio of Wanbury ?
The P/E ratio of Wanbury is 19.1 As on 10 May, 2024 | 00:08
What is the PB ratio of Wanbury ?
The PB ratio of Wanbury is -13.6 As on 10 May, 2024 | 00:08